RCVS 2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome

2019/01/11 by Eva A. Rocha, Eva Rocha, M. Akif Topcuoglu +4 · 26 citations
Medicine · #Cardiology #Cerebrovascular and genetic disorders #Internal medicine #Medicine #Moyamoya disease diagnosis and treatment #Neurological Complications and Syndromes #Reversible cerebral vasoconstriction syndrome #Vasoconstriction

paper · doi:10.1212/wnl.0000000000006917

openalex publication_date 2019/01/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Abstract

<h3>Objective</h3> To develop a method to distinguish reversible cerebral vasoconstriction syndrome (RCVS) from other large/medium-vessel intracranial arteriopathies. <h3>Methods</h3> We identified consecutive patients from our institutional databases admitted in 2013–2017 with newly diagnosed RCVS (n = 30) or non-RCVS arteriopathy (n = 80). Admission clinical and imaging features were compared. Multivariate logistic regression modeling was used to develop a discriminatory score. Score validity was tested in a separate cohort of patients with RCVS and its closest mimic, primary angiitis of the CNS (PACNS). In addition, key variables were used to develop a bedside approach to distinguish RCVS from non-RCVS arteriopathies. <h3>Results</h3> The RCVS group had significantly more women, vasoconstrictive triggers, thunderclap headaches, normal brain imaging results, and better outcomes. Beta coefficients from the multivariate regression model yielding the best <i>c</i>-statistic (0.989) were used to develop the RCVS₂ score (range −2 to +10; recurrent/single thunderclap headache; carotid artery involvement; vasoconstrictive trigger; sex; subarachnoid hemorrhage). Score ≥5 had 99% specificity and 90% sensitivity for diagnosing RCVS, and score ≤2 had 100% specificity and 85% sensitivity for excluding RCVS. Scores 3–4 had 86% specificity and 10% sensitivity for diagnosing RCVS. The score showed similar performance to distinguish RCVS from PACNS in the validation cohort. A clinical approach based on recurrent thunderclap headaches, trigger and normal brain scans, or convexity subarachnoid hemorrhage correctly diagnosed 25 of 37 patients with RCVS₂ scores 3–4 across the derivation and validation cohorts. <h3>Conclusion</h3> RCVS can be accurately distinguished from other intracranial arteriopathies upon admission, using widely available clinical and imaging features. <h3>Classification of evidence</h3> This study provides Class II evidence that the RCVS₂ score accurately distinguishes patients with RCVS from those with other intracranial arteriopathies.

Cited by

• Reversible cerebral vasoconstriction syndrome: Transcranial doppler findings in a case series of 90 patients
• Maternal Stroke: an Update. [europepmc]
• Primary Angiitis of the Central Nervous System: New Potential Imaging Techniques and Biomarkers in Blood and Cerebrospinal Fluid. [europepmc]
• Exploratory proteomic analysis implicates the alternative complement cascade in primary CNS vasculitis. [europepmc]
• Headache in cerebrovascular diseases. [europepmc]
• Potentially Reversible and Recognizable Acute Encephalopathic Syndromes: Disease Categorization and MRI Appearances. [europepmc]
• Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection. [europepmc]
• Catecholamine-induced cerebral vasospasm and multifocal infarctions in pheochromocytoma. [europepmc]
• Quantifying Intra-Arterial Verapamil Response as a Diagnostic Tool for Reversible Cerebral Vasoconstriction Syndrome. [europepmc]
• Recurrent thunderclap headaches from reversible cerebral vasoconstriction syndrome associated with duloxetine, xylometazoline and rhinitis medicamentosa. [europepmc]
• Stroke in Pregnancy: A Multidisciplinary Approach. [europepmc]
• Neurology of Preeclampsia and Related Disorders: an Update in Neuro-obstetrics. [europepmc]
• RCVS-TCH score can predict reversible cerebral vasoconstriction syndrome in patients with thunderclap headache. [europepmc]
• Early Risk of Readmission Following Hospitalization for Reversible Cerebral Vasoconstriction Syndrome. [europepmc]
• Reversible Cerebral Vasoconstriction Syndrome: Symptoms, Incidence, and Resource Utilization in a Population-Based US Cohort. [europepmc]
• A case of reversible cerebral vasoconstriction syndrome associated with anti-phospholipid antibody syndrome and systemic lupus erythematosus. [europepmc]
• Current Clinical Applications of Intracranial Vessel Wall MR Imaging. [europepmc]
• Reversible Cerebral Vasoconstriction Syndrome in Patients with Coronavirus Disease: A Multicenter Case Series. [europepmc]
• Reversible Cerebral Vasoconstriction Syndrome and Multisystem Inflammatory Syndrome in Children With COVID-19. [europepmc]
• Maternal Stroke Associated With Pregnancy. [europepmc]
• Vessel Wall Magnetic Resonance Imaging in Cerebrovascular Diseases. [europepmc]
• Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings. [europepmc]
• Spontaneous subarachnoid haemorrhage. [europepmc]
• Pathophysiology of reversible cerebral vasoconstriction syndrome. [europepmc]
• Reversible cerebral vasoconstriction syndrome: literature review. [europepmc]
• Complications of reversible cerebral vasoconstriction syndrome in relation to age. [europepmc]

Related

• The VASOGRADE
• Sensitivity of Early Brain Computed Tomography to Exclude Aneurysmal Subarachnoid Hemorrhage
• Clinical Associations and Causes of Convexity Subarachnoid Hemorrhage
• Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis
• Intracranial Aneurysms in Patients with Subarachnoid Hemorrhage: CT Angiography as a Primary Examination Tool for Diagnosis—Systematic Review and Meta-Analysis